Skip to main content
. 2021 Jul 6;13(14):3391. doi: 10.3390/cancers13143391
MS/MS tandem mass spectrometry
PTM post translation modifications
M mutated
U unmutated
P patient
progres. progressive
indol. indolent
SLL small lymphocytic lymphoma
ALL acute lymphoblastic leukemia
AML acute myeloid leukemia
BL Burkitt lymphoma
CML chronic myeloid leukemia
DLBCL diffuse large B cell lymphoma
HD healthy donors
RPPA Reverse Phase Protein Array
Cys Cysteine